Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$865M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$842M |
| 3 |
Direxion Daily 20+ Year Treasury Bull 3X Shares
TMF
|
+$787M |
| 4 |
iShares MSCI India ETF
INDA
|
+$760M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$725M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.17B |
| 3 |
Microsoft
MSFT
|
+$2.16B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Netflix
NFLX
|
+$865M |
Sector Composition
| 1 | Technology | 14.92% |
| 2 | Consumer Discretionary | 7.06% |
| 3 | Financials | 6.33% |
| 4 | Healthcare | 4.61% |
| 5 | Industrials | 4.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5201
BlackSky Technology
BKSY
$684M
| $81.8K | ﹤0.01% |
7,514
-14,069
| -65% | -$153K |
|
5202
Waldencast
WALD
$223M
| $81.7K | ﹤0.01% |
12,566
-97,902
| -89% | -$636K |
|
5203
Tredegar Corp
TG
$279M
| $81.7K | ﹤0.01% |
12,523
-3,443
| -22% | -$22.4K |
|
5204
CERo Therapeutics
CERO
$6.51M
| $81.4K | ﹤0.01% |
+13
| New | +$81.4K |
|
|
TWOU
5205
DELISTED
2U, Inc.
TWOU
| $81.3K | ﹤0.01% |
6,954
-14,956
| -68% | -$175K |
|
5206
Talkspace
TALK
$429M
| $80.5K | ﹤0.01% |
22,538
-33,412
| -60% | -$119K |
|
5207
Perspective Therapeutics
CATX
$258M
| $79.8K | ﹤0.01% |
6,706
+5,405
| +415% | +$64.3K |
|
5208
Repare Therapeutics
RPTX
$75.6M
| $79.8K | ﹤0.01% |
16,934
-11,501
| -40% | -$54.2K |
|
5209
Ribbon Communications
RBBN
$676M
| $79.5K | ﹤0.01% |
24,855
-23,047
| -48% | -$73.8K |
|
5210
Duluth Holdings
DLTH
$133M
| $79.5K | ﹤0.01% |
16,226
+4,788
| +42% | +$23.5K |
|
|
NIOBW
5211
NioCorp Developments Ltd. Warrant
NIOBW
$40.7M
| $78.4K | ﹤0.01% |
201,049
| – | – |
|
|
TCON
5212
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $78.4K | ﹤0.01% |
+9,115
| New | +$78.4K |
|
5213
Cantaloupe
CTLP
$792M
| $78.3K | ﹤0.01% |
12,176
-24,785
| -67% | -$159K |
|
5214
Prelude Therapeutics
PRLD
$64M
| $77.7K | ﹤0.01% |
16,388
-16,589
| -50% | -$78.6K |
|
5215
Immunic
IMUX
$78.4M
| $77.3K | ﹤0.01% |
+58,523
| New | +$77.3K |
|
|
SHCR
5216
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $77.2K | ﹤0.01% |
100,641
-35,339
| -26% | -$27.1K |
|
5217
Destination XL Group
DXLG
$80.3M
| $77.1K | ﹤0.01% |
21,407
-191,886
| -90% | -$691K |
|
5218
Gannett
GCI
$620M
| $77K | ﹤0.01% |
31,566
-64,080
| -67% | -$156K |
|
5219
Fractyl Health
GUTS
$72.2M
| $77K | ﹤0.01% |
+10,399
| New | +$77K |
|
5220
Accuray
ARAY
$177M
| $76.8K | ﹤0.01% |
31,087
-13,585
| -30% | -$33.6K |
|
|
NGM
5221
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $76.7K | ﹤0.01% |
48,238
-10,742
| -18% | -$17.1K |
|
5222
Heritage Global
HGBL
$65.7M
| $76.2K | ﹤0.01% |
28,878
-8,786
| -23% | -$23.2K |
|
5223
PetMed Express
PETS
$57.8M
| $76K | ﹤0.01% |
15,874
-17,381
| -52% | -$83.3K |
|
5224
StealthGas
GASS
$271M
| $75.6K | ﹤0.01% |
12,725
-163
| -1% | -$968 |
|
5225
MarketWise
MKTW
$49.2M
| $75.6K | ﹤0.01% |
2,184
+394
| +22% | +$13.6K |
|